Organic Letters
Letter
Strack, E. Pyocyanin, the blue pigment of Bacillus pyocyaneus. I.
Hoppe-Seyler's Z. Physiol. Chem. 1924, 140, 1−15. (c) Lau, G. W.;
Hassett, D. J.; Ran, H.; Kong, F. The role of pyocyanin in
Pseudomonas aeruginosa infection. Trends Mol. Med. 2004, 10,
599−606. (d) Jayaseelan, S.; Ramaswamy, D.; Dharmaraj, S.
Pyocyanin: production, applications, challenges and new insights.
World J. Microbiol. Biotechnol. 2014, 30, 1159−1168. (e) Meirelles, L.
A.; Newman, D. K. Both toxic and beneficial effects of pyocyanin
contribute to the lifecycle of Pseudomonas aeruginosa. Mol. Microbiol.
2018, 110, 995−1010. (f) Glasser, N. R.; Saunders, S. H.; Newman,
D. K. The Colorful World of Extracellular Electron Shuttles. Annu.
Rev. Microbiol. 2017, 71, 731−751. (g) Costa, K. C.; Glasser, N. R.;
Conway, S. J.; Newman, D. K. Pyocyanin degradation by a
tautomerizing demethylase inhibits Pseudomonas aeruginosa biofilms.
Science 2017, 355, 170−173.
(3) (a) Imai, S.; Furihata, K.; Hayakawa, Y.; Noguchi, T.; Seto, H.
Lavanducyanin, a new antitumor substance produced by Streptomyces
sp. J. Antibiot. 1989, 42, 1196−1198. (b) Nakayama, O.; Yagi, M.;
Tanaka, M.; Kiyoto, S.; Okuhara, M.; Kohsaka, M. WS-9659 A and B,
novel testosterone 5α-reductase inhibitors isolated from a Strepto-
myces. I. Taxonomy, fermentation, isolation, physico-chemical
characteristics. J. Antibiot. 1989, 42, 1221−1229. (c) Nakayama, O.;
Shigematsu, N.; Katayama, A.; Takase, S.; Kiyoto, S.; Hashimoto, M.;
Kohsaka, M. WS-9659 A and B, novel testosterone 5α-reductase
inhibitors isolated from a Streptomyces. II. Structural elucidation of
WS-9659 A and B. J. Antibiot. 1989, 42, 1230−1234. (d) Nakayama,
O.; Arakawa, H.; Yagi, M.; Tanaka, M.; Kiyoto, S.; Okuhara, M.;
Kohsaka, M. WS-9659 A and B, novel testosterone 5α-reductase
inhibitors isolated from a Streptomyces. III. Biological characteristics
and pharmacological characteristics. J. Antibiot. 1989, 42, 1235−1240.
(4) (a) Kondratyuk, T. P.; Park, E. J.; Yu, R.; van Breemen, R. B.;
Asolkar, R. N.; Murphy, B. T.; Fenical, W.; Pezzuto, J. M. Novel
Marine Phenazines as Potential Cancer Chemopreventive and Anti-
Inflammatory Agents. Mar. Drugs 2012, 10, 451−464. (b) Asolkar, R.
́
N.; Singh, A.; Jensen, P. R.; Aalbersberg, W.; Carte, B. K.; Feussner,
K. D.; Subramani, R.; DiPasquale, A.; Rheingold, A. L.; Fenical, W.
Marinocyanins, cytotoxic bromo-phenazinone meroterpenoids from a
marine bacterium from the streptomycete clade MAR4. Tetrahedron
2017, 73, 2234−2241.
(5) (a) Surrey, A. R. Pyocyanin. Org. Synth. 1946, 26, 86−90.
(b) Surrey, A. R. Pyocyanin. Org. Synth. Coll. 1955, 3, 753−756.
(6) (a) McIlwain, H. Phenazine series. VI. Reactions of
alkylphenazonium. salts; the phenazyls. J. Chem. Soc. 1937, 1704−
1711. (b) Mortzfeld, F. B.; Pietruszka, J.; Baxendale, I. R. A Simple
and Efficient Flow Preparation of Pyocyanin a Virulence Factor of
Pseudomonas aeruginosa. Eur. J. Org. Chem. 2019, 2019, 5424−5433.
(7) Kinoshita, Y.; Watanabe, H.; Kitahara, T.; Mori, K. Concise
construction of N-alkylated phenazinone skeletons: synthesis of
lavanducyanin (WS-9659A). Synlett 1995, 1995, 186−188.
̈
̈
(8) Frohner, W.; Reddy, K. R.; Knolker, H. J. Transition metals in
organic synthesis, Part 98. Transition metal mediated total synthesis
of the potent neuronal cell protecting alkaloid ( )-lavanduquinocin.
ARKIVOC 2012, 330−342.
D
Org. Lett. XXXX, XXX, XXX−XXX